Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-14

Clinical Trial Update: Inhaled Budesonide and Acute Mountain Sickness [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating inhaled budesonide for acute mountain sickness has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Inhaled budesonide (budesonide)

Snippet

Sponsor: Salzburger Landeskliniken | Conditions: Acute Mountain Sickness | Phase 1 | Status: COMPLETED